yearbook 2016 - eacr 1.pdf · anne-lise børresen-dale symposium 14:00 - 15:45 novel targeted...

In this issue:

Advancing cancer research: from basic research to prevention, treatment and care

NEW LOGO AND WEBSITE p.15

2016 MEMBERS’ SURVEY p.11

EACR24 CONGRESS PROGRAMME p.8

EACR AMBASSADOR PROGRAMME p.20

TRAVEL FELLOWSHIP AWARDS p.30

Yearbook2016

Y O U S E E A M O U S E .

Accelerate your oncology research with the JAX™ NSG mouse – the most immunodeficient strain available. See how the NSG is the obvious choice for your cancer xenograft modelling, immuno-oncology studies, stem cell research and challenging blood tumours. For more information or to enquire about model evaluation, visit us at www.criver.com/nsg.

W E S E E A C U R E F O R C A N C E R .

Charles River is the exclusive distributor of JAX™ Mice in Europe.

Y O U S E E A M O U S E .

Accelerate your oncology research with the JAX™ NSG mouse – the most immunodeficient strain available. See how the NSG is the obvious choice for your cancer xenograft modelling, immuno-oncology studies, stem cell research and challenging blood tumours. For more information or to enquire about model evaluation, visit us at www.criver.com/nsg.

W E S E E A C U R E F O R C A N C E R .

Charles River is the exclusive distributor of JAX™ Mice in Europe.

Through Sustaining Membership the EACR forms valuable partnerships with selected

organisations.

Sustaining Members support the vital work of the European Association for Cancer

Research in its fight against cancer and provide the means for the Association to develop.

The EACR gratefully acknowledges the support of its

Sustaining Members

Class 1 Laser Product.For Research Use Only. Not for use in diagnostic or therapeutic procedures.BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BDA085-02

BD Biosciences Erembodegem-Dorp 86 B - 9320 Erembodegembdbiosciences.com/eu

BD FACSseq™ Cell Sorter and BD™ Precise AssaysGene expression assays for single cells

The new BD FACSseq™ Cell Sorter selects thousands of individual cells, quickly discarding any dead/dying cells and then isolating them into PCR plates that contain preloaded BD™ Precise Reagents for your customized targeted gene expression assays. A much simplified workflow prepares the samples for absolute and direct molecular counting of transcripts by next generation sequencing (NGS), while minimizing amplification bias that can potentially occur in these crucial steps.

The affordable BD FACSseq Cell Sorter combined with BD Precise Assays lets you easily amp up your lab’s productivity to help ensure that your high quality single cell samples are ready for gene expression assays. And, you can significantly increase data accuracy and throughput while controlling costs.

Find out how at bdbiosciences.com/eu/s/facsseq

NGS-ready samples for gene expression Thousands of single cells, individually barcoded and indexed, now at the transcript level

8-9EACR24 Programme

6 President: Richard Marais

8 EACR24 Programme

10 Secretary General: Clare Isacke

11 EACR Members’ Survey Results

12 EACR24 Award Lectures

15 New logo and website

16 EACR Conference Series

20 Ambassador Programme

27 Susan G. Komen

28 Worldwide Cancer Research

29 EACR Secretariat

30 Travel Fellowship Awards

40 Sponsored Meetings

44 National Society Meetings

CONTENTS

Published by The European Association for Cancer Research, EACR

Secretariat, Sir Colin Campbell Building, Triumph Road, Nottingham, NG7 2TU

UK • Design and edit: Rachel Warden, Caroline Moulins • Liaison, collation

and advertising: Caroline Moulins • Additional design elements: freepik.com

EACR Yearbook

2016

EACR Yearbook 2016 5

Travel Fellowship Awards

EACR PresidentRichard Marais

20

New logo and website Members’ Survey Results

630

3%

7%

7%

19%

37%

61%

1115

months about the ESMO 2017 Congress in Partnership with EACR: this is an opportunity not to be missed.

CAREFOR project2015 also saw the EACR join with the EORTC and ESMO on the CAREFOR project – the Clinical Academic Cancer Research Forum. CAREFOR’s mission is to improve the delivery of academic clinical cancer trials in European oncology. I attended a meeting in Brussels in October 2015 where discussions were held with five Members of the European Parliament about the importance of academic clinical trials. Further developments will be announced as the project progresses.

New logo and websiteLast year also saw the introduction of a new logo for the EACR (see page 15) - and by the time you read this, a new EACR website will have been launched. We believe that this updated appearance and new user-focused website will help the EACR to continue to build our strong presence within the European and global cancer community. If there are new features you would like to see on our website, then we would be happy to hear from you.

EACR24 CongressAt the time of writing the EACR Congress, to be held 09-12 July in my home town of Manchester, is less than five months away. As Congress and Scientific Chair I strongly encourage you not to miss out: the ‘regular rate’ deadline is 30 May. You can find more reasons to attend over the next three pages - including details of the rich and varied scientific programme and the outstanding line-up of speakers.

I wish you every success in 2016 and I hope to see you in Manchester in July.

Richard Marais

is President of the EACR and Director of the CRUK Manchester Institute, UK

EACR Yearbook 2016

EACR President: Richard Marais

6

EACR President: Richard Marais

We aim to bring together different perspectives from both sides of the lab bench

It is my pleasure to introduce the 2016 EACR Yearbook, which describes our activities and achievements of the

past year and tells you of the new opportunities the next year will bring.

New Partnership with ESMO2015 brought exciting developments for the EACR. We formed a major new partnership with the European Society for Medical Oncology (ESMO). There is a natural link between our associations that the leaderships of both are keen to develop. We aim to bring together different perspectives from both sides of the lab bench in order to enable even greater cooperation and exchange of ideas between basic and translational researchers and their clinical colleagues.

An important result of this new relationship is that in 2017 and 2019 the EACR will be an active partner in the ESMO Congress. This will give EACR members the opportunity to attend a major congress - in addition to the EACR Biennial Congress - with a reduced registration rate, programme tracks of real interest and relevance, and opportunities to exchange knowledge with the medical oncology community. We have also recently partnered on the ‘ESMO Symposium on Signalling Pathways in Cancer’ (Sitges, Barcelona, 04-05 March 2016), co-chaired by the EACR Secretary General Clare Isacke, and I was pleased to see so many EACR members in attendance.

Make sure you look out for further details over the coming

24th Biennial Congress of the European Association for Cancer Research

From Basic Research to

Precision Medicine

• Cancer Immunology• Tumour Heterogeneity

and Evolution• Cancer Immunotherapy• The Tumour

Microenvironment• DNA Damage• Mechanisms of Drug

Resistance• Liquid Biopsies in Cancer

• Tumour Metabolism• Epigenetics• Senescence and Ageing • Diagnosing Cancer Earlier• Novel Targeted Therapies• Signalling Networks in

Cancer• Stem Cells• Invasion and Metastasis• InflammationandCancer

• Breakthrough Tools in Cancer Genetics

• Tumour Suppressors• Breakthrough Cancer

Models• Precision Medicine• Workshop: Women in

Science• Workshop: Young Cancer

Researchers

Innovation Pushing the agenda to make precision medicine a reality

Sharing Poster sessions and proffered papers will allow researchers at all levels to share their discoveries

Focus Participants can create a

tailor-made programme from the 3 parallel tracks covering 18 priority areas

Networking Excellent opportunities to meet new contacts and develop new collaborations

Breadth The EACR Congress is Europe’s largest

dedicated conference on basic and translational research

Location The venue is

right in the heart of Manchester and

the airport is a major international hub

See the full programme at

eacr24.eacr.org

SeSSion toPicS include:

eAcR24 will offer...


EACR24 Programme

Saturday 09 July 2016 Sunday 10 July 2016

Symposium08:30 - 10:15

Tumour Heterogeneity and Evolution

Chair: Carlos CaldasLevi GarrawayCarlos Caldas

Symposium 08:30 - 10:15

DNA DamageChair: Stephen Jackson

Fabrizio D’Adda Di FagagnaDon W. ClevelandStephen Jackson

Symposium 08:30 - 10:15

Tumour MetabolismChair: Karen Vousden Matt Vander Heiden

Eyal GottliebCeleste Simon

Coffee Break / Poster Viewing / Exhibition10:15-10:45

Symposium 10:45 - 12:30

Cancer Immunotherapy

Chair: Caroline RobertZelig Eshhar

Santiago Zelenay Caroline Robert

Symposium 10:45 - 12:30

Mechanisms of Drug Resistance

Chair: Daniel PeeperRavid Straussmann

Susan GalbraithDaniel Peeper

Symposium 10:45 - 12:30Epigenetics

Chair: Geneviève Almouzni Rolf Ohlsson

Maarten van LohuizenGeneviève Almouzni

Poster Viewing / Exhibition

12:30 - 14:00

Satellite Symposium 12:30-14:00


Young Researcher Workshop13:00 - 14:00

Coordinators: Eli PikarskyEmmy Verschuren

Symposium 14:00 - 15:45The Tumour

MicroenvironmentChair: Clare Isacke

Kristian PietrasAlan Serrels

Peter S. Nelson

Symposium 14:00 - 15:45

Liquid Biopsies in Cancer

Chair: Caroline DiveAlberto Bardelli

Klaus PantelCaroline Dive

Symposium 14:00 - 15:45

Senescence and Ageing

Chair: Clemens SchmittValery Krizhanovsky

William KeyesClemens Schmitt

Coffee Break 15:45 - 16:15

Poster Defence / Exhibition15:45-17:15

OECI supported Plenary Symposium

15:30 - 17:00Cancer ImmunologyChair: Christof von Kalle

James P. AllisonAdrian Hayday

Paul Tumeh

Opening Address 13:00 - 13:15

Mühlbock Lecture13:15 - 14:15

Chair: Moshe OrenKaren Vousden

Worldwide Cancer Research Lecture

14:15 - 15:00Chair: Anton BernsMariano Barbacid


Opening Ceremony /Opening Lecture

17:00-17:50 Chair: Richard Marais

David Livingston

Followed by Exhibitors’ Welcome

Reception18:00 - 19:30

Anthony Dipple Carcinogenesis

Award17:15 - 18:00

Chair: Curtis C. HarrisMichael Karin

Carcinogenesis Young

Investigator’s Award18:00 - 18:45

Chair: Curtis C. HarrisLudmil B. Alexandrov

Exhi

bitio

n

1

4.45

- 2

0.00

Exhi

bitio

n

1

0:00

- 1

7.15

Post

er V

iew

ing

10:

15 -

17.

15

EACR General AssemblyCharter 4

19:00 - 19.45

Special SessionExchange Room 9

19:00 - 20:30

Central Hall 1 Exchange Hall Charter 1

Register at eacr24.eacr.org

EACR Yearbook 20168

Tuesday 12 July 2016Monday 11 July 2016

ESMO Symposium08:30 - 10:15

Clinical Developments in the Diagnosis and Treatment of Solid

TumoursChairs: Richard Marais & Fortunato Ciardiello

Fabrice AndréFortunato Ciardiello

Rolf Stahel

Symposium 08:30 - 10:15Stem Cells

Chair: Sean MorrisonCedric Blanpain Connie J. EavesSean Morrison

Symposium 08:30 - 10:15

Breakthrough Tools in Cancer Genetics

Chair: Emmy VerschurenMats Nilsson

Zoltan Szallasi Serena Nik-Zainal

Coffee Break / Poster Viewing / Exhibition10:15-10:45

Symposium 10:45 - 12:30

Diagnosing Cancer Earlier

Chair: Paul PharoahWilliam C. Hahn

Yoryos LyratzopoulosPaul Pharoah

BACR supported Symposium 10:45 - 12:30

Invasion and MetastasisChairs: Michelle Garrett

& Ingunn Holen Erik Sahai

Gerhard ChristoforiMargaret Frame

Symposium 10:45 - 12:30

Tumour Suppressors Chair: Moshe Oren

Xin LuScott Lowe

Moshe Oren

Poster Viewing / Exhibition

12:30 - 14:00



Young Researcher Workshop13:00 - 14:00

Women in ScienceCoordinators: Françoise

MeunierAnne-Lise Børresen-Dale

Symposium 14:00 - 15:45

Novel Targeted Therapies

Chair: Joan SeoaneTim SomervailleStefan PfisterJoan Seoane

Symposium 14:00 - 15:45

Inflammation and Cancer

Chair: Eli PikarskyKarin de Visser

Alberto MantovaniEli Pikarsky

Symposium 14:00 - 15:45

Breakthrough Cancer Models

Chair: Ultan McDermottRichard A. Flavell

Chris BakalUltan McDermott


Poster Defence / Exhibition15:45-17:15

Plenary Symposium 10:45 - 12:15

Precision MedicineChair: Carlos CaldasJean-Charles Soria

further speakers to be announced

Plenary Lecture08:45 - 09:30

Chair: Donatella Del BufaloAnton Berns

Pezcoller Foundation - EACR Cancer Researcher Award

Lecture09:30 - 10:15

Chair: Moshe OrenYardena Samuels

Coffee Break 10:15-10:45

Closing Remarks, Poster Awards

and EACR24 Highlights 12:30

Mike Price Gold Medal Award Lecture

12:50 - 13:30Chair: Anton Berns

Mike Stratton

Plenary Symposium17:15 - 18:45

Signalling Networks in Cancer

Chair: Joan SeoaneMichael Yaffe

Douglas A. Lauffenburger

Congress Dinner20:00 - 22:30

Exhi

bitio

n

1

0:00

- 1

7.15

Post

er V

iew

ing

10:

15 -

17.

15

Central Hall 1 Exchange Hall Charter 1


Clare Isackeis Secretary General of the EACR and a Professor at the Breast Cancer Now Research Centre, Institute of Cancer Research, London, UK

Secretary General: Clare Isacke

EACR Members’ Survey

I would like to thank you if you are one of the many EACR members who completed the 2016

Members’ Survey. We received a huge number of well-considered responses: you told us about the challenges you face as cancer researchers, about your EACR membership, what it means to belong to a community like the EACR, and how we can strengthen and develop the Association still more in the years to come.

On the facing page you can see a graphical summary of some of the data obtained from the survey. Of course the most valuable feedback we received was all of your thoughtfully written comments, ideas and suggestions. These cannot be summarised here, but we are using them to inform our future activities.

EACR Conference Series

EACR members will be very familiar with the EACR Conference Series. 2015 was a great year for the Conference Series, with six successful meetings including our first special conference organised in partnership with the AACR and SIC (Società Italiana di Cancerologia) on ‘Anticancer Drug Action and Drug Resistance’ in Florence, Italy. You can read more about the Conference Series on pages 16-18.

EACR General Assembly at the EACR24 CongressI’d like to invite you to attend the EACR Members’ General Assembly at the EACR24 Congress in Manchester, which will be held on Sunday 10 July

at 19.00, just after the close of the day’s scientific sessions. This will be great opportunity for you to meet other EACR members and network, as well as vote on important EACR business and congratulate this year’s award winners. The event will be followed by a buffet reception – please remember to sign up on the EACR24 website.

‘Solo Travellers’ Meet and Greet hosted by EACR AmbassadorsOn the first day of EACR24 we are organising an informal social event for those attending the Congress on their own. This gives ‘solo travellers’ the opportunity to meet other participants and make new contacts before the scientific sessions begin. If you are interested, please sign up to attend on the EACR24 website. The event will be hosted by some of our EACR Ambassadors: to read more about the EACR Ambassador Programme see pages 20-22.

Retirement of Robert Kenney, EACR Executive Director2015 saw the retirement of the EACR’s Executive Director of nine years, Robert Kenney. I had the pleasure of working with Rob for several years in my role as a Board member and Secretary General, and I wish him all the best for the future. You can read more about Rob’s time at the EACR on page 29.

Finally, I would like to take this opportunity to welcome our new EACR Chief Operating Officer, Jane Smith, whom you can meet at the General Assembly in Manchester.

you told us about what it means to belong to a community like the EACR

EACR Yearbook 201610

EACR Members’ Survey 2016Would you recommend EACR membership to others?

98%said ‘Yes’

48% had been in contact with the EACR Secretariat.

Excellent 48% Very good 38% Satisfactory 12%

Students

Postdoc <4 years since PhD

Postdoc >4 years since PhD

Principal investigator/team leader

Senior level scientist

Other

24%

17%

13%

22%

15%

9%

Level of seniority Where do members work? Which areas do members work in?

University department

Cancer research centre/institute

Hospital

Comprehensive cancer centre

Other

Industry3%

7%

7%

19%

37%

61%

Basic research

Translational research

Clinical research

Medical doctor

Other

Epidemiology4%

6%

13%

22%

54%

66%

100%0%

Communication via email bulletin

% who rated the benefit

‘valuable’

% who said they had usedthebenefit

Reduced registration fee at Conference

Series

Reduced registration fee

at Congress

Travel Fellowships

Meeting Bursaries

Ability to apply for Meeting Sponsorship

Opportunity to join

Ambassador programme

50%0%

50%

100%

Usage

Value

Membershipbenefits:valuevs.usage

9 out of 10 identifiedatleastonebenefittheyhavenotused but would like

to use in future

10% 20% 30% 40% 60% 70% 80% 90%

10%

20%

30%

40%

60%

70%

80%

90%

Sent to EACR members in January 2016

72% use ResearchGate

62% use Linkedin

60% use Facebook

15% use Twitter

11% do not use social media

Social media use

They rated the experience...


EACR24 Award Lectures

The Mike Price Gold Medal Award

The Mike Price Gold Medal is presented biennially to a senior

researcher who has made an exceptional contribution to cancer research in Europe.

The 2016 award will be presented to Professor Sir Michael Stratton.

Professor Stratton will receive the Mike Price Gold Medal and deliver the

closing lecture at EACR24.

Mike Stratton is Director of the Wellcome Trust Sanger Institute. His primary research interests have

been in the genetics of cancer. His early research focused on inherited susceptibility. He mapped and identified the

The Pezcoller Foundation-EACR Cancer Researcher Award

Carcinogenesis Awards

major high risk breast cancer susceptibility gene BRCA2 and subsequently a series of moderate risk breast cancer and other cancer susceptibility genes.

In 2000 he initiated the Cancer Genome Project at the Wellcome Trust Sanger Institute which conducts systematic genome-wide searches for somatic mutations in human cancer. Through these studies he discovered somatic mutations of the BRAF gene in malignant melanoma and several other mutated cancer genes in lung, renal, breast and other cancers. He has described the basic patterns of somatic mutation in cancer genomes revealing underlying DNA mutational and repair processes.

He is a Fellow of the Royal Society (FRS) and was knighted by the Queen in 2013.

The Pezcoller Foundation – EACR Cancer Researcher Award is presented biennially to a researcher of excellence

with no more than 15 years post-doctoral experience. The winner will receive an honorarium of €10,000 and give the prestigious Pezcoller Foundation – EACR Award Lecture at the EACR24 Congress.

The winner of the 2016 Pezcoller Foundation – EACR Cancer Researcher Award is Professor Yardena Samuels.

Yardena Samuels is a tenured Associate Professor at the Weizmann Institute, where she is the Incumbent of the Knell Family Professorial Chair. She is also the director of the

Ekard Institute for Cancer Diagnosis Research of the Moross Integrated Cancer Centre.

The Samuels laboratory uses various sequencing approaches to

identify the genetic changes that underlie melanoma. Once these mutations are identified, her group focuses on characterising the biochemical, functional, and clinical aspects of the most highly mutated genes.

Mike Price Gold Medal Award Lecture at EACR24: Tuesday 12 July, 12.50-13.30

Award Lecture: Tuesday 12 July, 09.30-10.15Award Lecture: Sunday 10 July, 17.15-18.00

Anthony Dipple Carcinogenesis Award

Carcinogenesis Young Investigator’s Award

Michael Karin, University of California, San Diego, USA.

Dr. Karin has spent his entire academic career investigating stress and inflammation signalling covering the entire gamut of research approaches from basic biochemistry through molecular cell biology to animal pathophysiology. Through this work, Dr. Karin has contributed to the founding of the Inflammation and Cancer field.

Award Lecture: Sunday 10 July, 18.00-18.45

12

Ludmil B. Alexandrov, Los Alamos National Laboratory, Los Alamos, USA.

Ludmil Alexandrov is an Oppenheimer Fellow in the Theoretical Biology and Biophysics Group and the Center for Nonlinear Studies at Los Alamos National Laboratory. In 2014, he was recognised by Forbes magazine as one of the “30 brightest stars under the age of 30” in the field of Science and Healthcare. In 2015, his research was highlighted by the American Society of Clinical Oncology as an important step forward in the fight against cancer.

Discover actionable biomarkers from solid tumor samples Unmatched genome-wide copy number analysis with a single assay

OncoScan® FFPE Assay Kit delivers

n Whole-genome copy number from only 80 ng of FFPE-derived DNA

n Copy-neutral loss of heterozygosity (cnLOH) and somatic mutation analysis

n Dynamic detection range of 50+ copies; high confidence in detecting low-level amplifications (<8 copies)

n Free analysis software, including a visual overlay of functional genomic data with DNA copy number variations

Visit www.affymetrix.com/oncoscan©2015 Affymetrix, Inc. All rights reserved. For Research Use Only. Not for use in diagnostic procedures.

OncoScan® FFPE Assay KitGenome-wide copy number in 48 hours

EACR yearbook 2016_Affy_OncoScan_FFPE_Assay_Kit_biomarkers_Ad_DDN_3.indd 1 11/02/2016 18:30:21

June 3-7, 2016McCormick Place | Chicago, Illinois | #ASCO16

Join us in Chicago for the world’s premier oncology event. This year’s presidential theme by Dr. Julie Vose is Collective Wisdom: The Future of Patient-Centered Care and Research. Our collective wisdom, spanning across all cancer specialties and new areas of scientific inquiry, will shape the future of patient-centered research and high-quality cancer care. Collaborate with and learn from your colleagues at the 2016 ASCO Annual Meeting.

Hotel Reservation and Early Registration Deadline:April 27, 2016, at 11:59 PM (EDT)

Register and reserve your hotel today at am.asco.org

REGISTRATION & HOTEL RESERVATIONS NOW OPEN

Announcing a new EACR logo

Old logo: c. 1990s to 2015 New logo: 2015 and beyond...

In September 2015 we launched a new logo to reflect the EACR’s growing presence as a modern and professional

organisation.

The old logo served the EACR well for many years. We do not

New website www.eacr.orgWe’ve designed our new website with you in mind: we want it to be as easy for you to use as possible.

Mobile... It’s device responsive so it’s just as convenient to browse on your phone as on your desktop.

Searchable... Search for a conference by topic or location... search for a job opportunity by type... search for other members based on their name, expertise or where they work.

Shareable... Easily share any page with just a few clicks. Share news items, job opportunities and announcements via email or social media.

... and a new website!

know exactly in which year it was first introduced, as many of the EACR’s oldest records were destroyed in a flood in 2007.

If any members can remember in which year the old logo was introduced, we would be very pleased to hear from you!

We’d love to hear your feedback on the new website.Contact the Secretariat: eacr.org/contact-us


yearbook 2016 - eacr 1.pdf · anne-lise børresen-dale symposium 14:00 - 15:45 novel targeted...

Documents